These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37909533)

  • 1. Relationship of irisin expression with metabolic alterations and cardiovascular risk in type 2 diabetes mellitus: a preliminary study.
    Mathia VL; Mendonça MIS; Simões DP; Perez MM; Alves BDCA; Encinas JFA; Raimundo JRS; Arcia CGC; Murad N; Fonseca FLA; Veiga GLD
    Rev Assoc Med Bras (1992); 2023; 69(12):e20230812. PubMed ID: 37909533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Usefulness of Diagnostic Panels Based on Circulating Adipocytokines/Regulatory Peptides, Renal Function Tests, Insulin Resistance Indicators and Lipid-Carbohydrate Metabolism Parameters in Diagnosis and Prognosis of Type 2 Diabetes Mellitus with Obesity.
    Komosinska-Vassev K; Gala O; Olczyk K; Jura-Półtorak A; Olczyk P
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32917052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case-control study to evaluate irisin levels in patients with type 1 diabetes mellitus.
    Abdulabbas DA; Hassan EA
    Ir J Med Sci; 2024 Jun; 193(3):1275-1282. PubMed ID: 38349510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irisin is a predictor of sarcopenic obesity in type 2 diabetes mellitus: A cross-sectional study.
    Oguz A; Sahin M; Tuzun D; Kurutas EB; Ulgen C; Bozkus O; Gul K
    Medicine (Baltimore); 2021 Jul; 100(26):e26529. PubMed ID: 34190188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ratio of skeletal muscle mass to visceral fat area is a main determinant linking circulating irisin to metabolic phenotype.
    Hwang YC; Jeon WS; Park CY; Youn BS
    Cardiovasc Diabetol; 2016 Jan; 15():9. PubMed ID: 26790404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between myostatin and irisin in type 2 diabetes mellitus: a compensatory mechanism to an unfavourable metabolic state?
    García-Fontana B; Reyes-García R; Morales-Santana S; Ávila-Rubio V; Muñoz-Garach A; Rozas-Moreno P; Muñoz-Torres M
    Endocrine; 2016 Apr; 52(1):54-62. PubMed ID: 26438394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of Irisin Hormone Level in Type 2 Diabetic Patients and Patients with Diabetic Nephropathy.
    Shelbaya S; Abu Shady MM; Nasr MS; Bekhet MM; Mageed YA; Abbas M
    Curr Diabetes Rev; 2018; 14(5):481-486. PubMed ID: 28875825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D supplementation improves SIRT1, Irisin, and glucose indices in overweight or obese type 2 diabetic patients: a double-blind randomized placebo-controlled clinical trial.
    Safarpour P; Daneshi-Maskooni M; Vafa M; Nourbakhsh M; Janani L; Maddah M; Amiri FS; Mohammadi F; Sadeghi H
    BMC Fam Pract; 2020 Feb; 21(1):26. PubMed ID: 32033527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obese with higher FNDC5/Irisin levels have a better metabolic profile, lower lipopolysaccharide levels and type 2 diabetes risk.
    Bonfante ILP; Chacon-Mikahil MPT; Brunelli DT; Gáspari AF; Duft RG; Oliveira AG; Araujo TG; Saad MJA; Cavaglieri CR
    Arch Endocrinol Metab; 2017 Dec; 61(6):524-533. PubMed ID: 29412381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Irisin Circulating Level with Diabetic Retinopathy: A Case-Control Study.
    Tarboush NA; Abu-Yaghi NE; Al Ejeilat LH; Wahed RKA; Jeris IN
    Exp Clin Endocrinol Diabetes; 2021 Jan; 129(1):36-42. PubMed ID: 30223289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Potential Relationship Between Serum Irisin Concentration With Inflammatory Cytokines, Oxidative Stress Biomarkers, Glycemic Indices and Lipid Profiles in Obese Patients With Type 2 Diabetes Mellitus: A Pilot Study.
    Khajebishak Y; Faghfouri AH; Soleimani A; Ilaei S; Peyrovi S; Madani S; Payahoo L
    J ASEAN Fed Endocr Soc; 2023; 38(1):45-51. PubMed ID: 37252420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating asprosin, irisin, and abdominal obesity in Chinese patients with type 2 diabetes mellitus: a case-control study.
    Hu G; Si W; Zhang Q; Lv F
    Endokrynol Pol; 2023; 74(1):55-62. PubMed ID: 36537187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma irisin is elevated in type 2 diabetes and is associated with increased E-selectin levels.
    Rana KS; Pararasa C; Afzal I; Nagel DA; Hill EJ; Bailey CJ; Griffiths HR; Kyrou I; Randeva HS; Bellary S; Brown JE
    Cardiovasc Diabetol; 2017 Nov; 16(1):147. PubMed ID: 29121940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irisin and leptin concentrations in relation to obesity, and developing type 2 diabetes: A cross sectional and a prospective case-control study nested in the Normative Aging Study.
    Sahin-Efe A; Upadhyay J; Ko BJ; Dincer F; Park KH; Migdal A; Vokonas P; Mantzoros C
    Metabolism; 2018 Feb; 79():24-32. PubMed ID: 29108900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum irisin levels in new-onset type 2 diabetes.
    Choi YK; Kim MK; Bae KH; Seo HA; Jeong JY; Lee WK; Kim JG; Lee IK; Park KG
    Diabetes Res Clin Pract; 2013 Apr; 100(1):96-101. PubMed ID: 23369227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of serum levels of Irisin as a marker of endothelial dysfunction in patients with type 2 diabetes mellitus.
    Ahmed TM; Nassar M; Mohamed HAA; Elhadidy KE; Farhan HM; El Basset ASA; Elmessiery RM; Kamel MF
    Endocrinol Diabetes Metab; 2023 May; 6(3):e403. PubMed ID: 36919265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inverse correlation between serum irisin and cardiovascular risk factors among Chinese overweight/obese population.
    Liu R; Zhang Q; Peng N; Xu S; Zhang M; Hu Y; Chen Z; Tang K; He X; Li Y; Shi L
    BMC Cardiovasc Disord; 2021 Nov; 21(1):570. PubMed ID: 34847893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between Irisin, hs-CRP, and Metabolic Status in Children and Adolescents with Type 2 Diabetes Mellitus.
    Elizondo-Montemayor L; Gonzalez-Gil AM; Tamez-Rivera O; Toledo-Salinas C; Peschard-Franco M; Rodríguez-Gutiérrez NA; Silva-Platas C; Garcia-Rivas G
    Mediators Inflamm; 2019; 2019():6737318. PubMed ID: 31015797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irisin levels in the progression of diabetes in sedentary women.
    Duran ID; Gülçelik NE; Ünal M; Topçuoğlu C; Sezer S; Tuna MM; Berker D; Güler S
    Clin Biochem; 2015 Dec; 48(18):1268-72. PubMed ID: 26234637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with increased irisin levels in the type 1 diabetes mellitus.
    Ates I; Arikan MF; Erdogan K; Kaplan M; Yuksel M; Topcuoglu C; Yilmaz N; Guler S
    Endocr Regul; 2017 Jan; 51(1):1-7. PubMed ID: 28222023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.